Lam Research Corporation
NASDAQ:LRCXSemiconductors
+$19.70 today
- Market cap
- $264.41B
- Beta
- 1.87
- P/E (TTM)
- 73.4
- EPS (TTM)
- $5.37
- Dividend yield
- 0.26%
Volume 7.61M
Average 11.84M
LRCX Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Lam Research CorporationNASDAQ: LRCX
Depreciation & Amortization · Q1 FY2027 · quarter ended Sep 2026
Depreciation & amortization growth accelerates
Q1 FY2027 depreciation & amortization of $122.07M rose 20.1% year over year, ahead of the +17.4% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 2.0% from the prior quarter. Over 3 fiscal years it compounded at +8.8% a year.
Context
- Depreciation & amortization amounted to 1.9% of revenue in FY2026, down 0.2 pp from a year earlier.
- Depreciation & amortization increased in 3 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +20.1% holds above the trailing-twelve-month pace of +17.4%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2026
- 441.53M USD
- Year-over-year change
- +14.3%
- 4-year CAGR
- +7.2%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2026 | 2026-06-28 | 441.53M | +14.3% |
| FY2025 | 2025-06-29 | 386.28M | +7.4% |
| FY2024 | 2024-06-30 | 359.7M | +5.0% |
| FY2023 | 2023-06-25 | 342.43M | +2.6% |
| FY2022 | 2022-06-26 | 333.74M | — |
Depreciation & Amortization vs competitors
How LRCX compares with its peers on the latest reported figures
- Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +17.4% is the 3rd highest of 6, against a peer median of +1.2%.
- Depreciation & amortization amounts to 1.8% of revenue for LRCX, versus a peer median of 2.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | €1.02B EUR | +1.2% | +20.7% | 2.6% | |
| LTM Oct 2026 | $571M USD | +32.5% | +3.5% | 1.7% | |
| LTM Sep 2026 | $461.96M USD | +17.4% | +8.8% | 1.8% | |
| LTM Jun 2026 | $393.98M USD | -0.0% | -1.7% | 2.9% | |
| LTM Jun 2026 | $21.74M USD | +86.8% | +44.9% | 2.1% | |
| LTM Sep 2026 | $19.83M USD | -5.7% | -7.9% | 2.7% | |
| Peer median (excluding LRCX) | — | +1.2% | +3.5% | 2.6% | |
Competitors are the stored peer set for LRCX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 | FY2026 Jun 2026 |
|---|---|---|---|---|---|
| Net Income | 4.61B | 4.51B | 3.83B | 5.36B | 7.27B |
| Depreciation & Amortization | 333.74M | 342.43M | 359.7M | 386.28M | 441.53M |
| Deferred Income Tax | (257.44M) | (172.06M) | (198.98M) | (363.25M) | (289.06M) |
| Stock-Based Compensation | 259.06M | 286.6M | 293.06M | 343.37M | 386.38M |
| Change in Working Capital | (1.8B) | 158.74M | 360.48M | 441.8M | (1.91B) |
| Accounts Receivables | (1.29B) | 1.45B | 303.44M | (858.75M) | 0 |
| Inventory | (1.35B) | (961.97M) | 528.72M | (180.73M) | 0 |
| Accounts Payables | 167.88M | (522.2M) | 125.94M | 212M | 0 |
| Other Working Capital | 674.91M | 190.65M | (597.63M) | 1.27B | (1.91B) |
| Other Non-Cash Items | (44.75M) | 52.3M | 10.24M | 6.85M | (32.71M) |
| Operating Cash Flow | 3.1B | 5.18B | 4.65B | 6.17B | 5.86B |
| Capital Expenditures | (546.03M) | (501.57M) | (396.67M) | (759.19M) | (966.41M) |
| Acquisitions (Net) | 0 | (119.96M) | 0 | 0 | 0 |
| Purchases of Investments | (567.82M) | (98.13M) | 0 | 0 | 0 |
| Sales of Investments | 1.73B | 98.13M | 37.77M | 0 | 0 |
| Other Investing Activities | (7.58M) | 86.96M | (11.71M) | 51.09M | 44.25M |
| Investing Cash Flow | 612.28M | (534.56M) | (370.61M) | (708.09M) | (922.15M) |
| Debt Repayment | (11.89M) | (23.21M) | (256.1M) | (507.49M) | (755.43M) |
| Common Stock Issued | 5.68M | 11.11M | 15.55M | 142.57M | 17.45M |
| Common Stock Repurchased | (3.87B) | (2.02B) | (2.84B) | (3.42B) | (3.85B) |
| Dividends Paid | (815.29M) | (907.91M) | (1.02B) | (1.15B) | (1.27B) |
| Other Financing Activities | 108.22M | 106.35M | 106.42M | 143K | 142.17M |
| Financing Cash Flow | (4.58B) | (2.83B) | (4B) | (4.94B) | (5.72B) |
| Effect of Forex Changes | (30.23M) | 128K | (22.37M) | 28.32M | (27.43M) |
| Net Change in Cash | (897.22M) | 1.81B | 263.43M | 556.85M | (809.71M) |
| Free Cash Flow | 2.55B | 4.68B | 4.26B | 5.41B | 4.89B |
Lam Research Corporation
NASDAQ:LRCX
Intrinsic Alpha fair value
Locked
Current Price
$211.67
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.